A comprehensive view of pharmaceuticals/nutraceuticals. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

CDMO firm Piramal Pharma Solutions opens new C$30M, 10,000 square-foot API plant in Aurora, Ontario, with two reactor suites, filtration, drying capabilities; plant capable of making highly potent APIs that require OEL of 1mcg/m3

Pfizer resists requests for research supplies of oral COVID-19 drug Paxlovid from researchers looking to lower chance of drug resistance; Pfizer to test Paxlovid-style drug later this year, as company projects US$22B in global Paxlovid sales this year

Emergent BioSolutions receives exclusive global rights to Chimerix’s oral brincidofovir, including Tembexa, an FDA-approved medical countermeasure for smallpox, for US$325M; Chimerix in negotiations with BARDA for Tembexa procurement contract

Merck signs licensing deal for Sichuan Kelun Pharmaceutical’s oncology program for areas outside of China, Hong Kong, Macao, Taiwan; deal worth US$1.4B and may relate to experimental drugs SKB264 or A166 currently in Phase 2 testing in China

Novavax expects to start Phase 2 COVID-19, flu combined vaccine trial by end of 2022; initial Phase 1/2 trial data show various formulations of the combination vaccine induced immune responses in participants comparable to stand-alone shots

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count